Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Dianthus Therapeutics, Inc. DNTH

Set alert

Price alert · DNTH

All alert types
82.25 USD -0.13 -0.16%

At close · Nov 2

81.50 -0.75 -0.91%

After hours · Nov 2, 4:00 PM ET

Bid
82.25 × 2
Ask
82.36 × 2
80.75 Day range 84.56
32.42 52-week range 117.88
YTD
+99.59%
1 year
+135.13%
Open
82.46
Prev close
82.38
Mkt cap
4.60B
Vol
837.80K
Avg vol
813.26K
EPS
-4.24
P/E
0.00
Div yield
0.00%
More statistics
Low
80.75
High
84.56
Forward P/E
-17.84
Beta
0.26
Short ratio
9.16
Inst. own
129.89%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
92.76
200-d avg
85.03
1y target
139.06

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 4, 2026Earnings: -0.9; estimate -0.84628; surprise -6.35%
  • Aug 6, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Aug 6, 2026Rating: Truist Securities · Buy → Buy
  • Sep 4, 2026Rating: Citigroup · — → Buy
  • Sep 11, 2026Rating: JP Morgan · — → Overweight
  • Oct 15, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 27, 2026Rating: Roth Capital · — → Buy
Signals (9)
NameDateAgo
MACD: Buy SignalOct 21, 20261 week ago
RSI: OversoldSep 25, 20261 month ago
SMA: BearishSep 15, 20261 month ago
SMA: BullishSep 11, 20261 month ago
SMA: BearishSep 10, 20261 month ago
SMA: BearishAug 28, 20262 months ago
MACD: Sell SignalAug 19, 20262 months ago
MACD: Buy SignalAug 14, 20262 months ago
MACD: Sell SignalAug 11, 20262 months ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 139.06 +69.1% upside
Target (low)
113.00
Target (mean)
139.06
Target (high)
200.00
Ratings (0m) 18 18 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy17
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 18
  • 1 month ago 17
  • 2 months ago 15

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

DNTH analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.94865-1.13 – -0.3929-0.97+2.2%388.66K-1.8%10
Next quarter-1.11-1.36 – -0.9841-1.43+22.3%309.11K+8.8%10
Current year-3.81-4.10 – -3.43-4.20+9.2%1.92M-5.8%11
Next year-4.61-5.77 – -3.47-3.81-20.9%1.82M-5.0%11

Upgrades and downgrades

The latest rating changes

DNTH analyst upgrades and downgrades
DateFirmActionFromTo
Oct 27, 2026Roth CapitalInitiated—Buy
Oct 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 11, 2026JP MorganInitiated—Overweight
Sep 4, 2026CitigroupInitiated—Buy
Aug 6, 2026Truist SecuritiesMaintainedBuyBuy
Aug 6, 2026HC Wainwright & Co.MaintainedBuyBuy
Aug 5, 2026WedbushMaintainedOutperformOutperform
Aug 3, 2026Evercore ISI GroupMaintainedOutperformOutperform
May 6, 2026WedbushMaintainedOutperformOutperform
Apr 9, 2026Wolfe ResearchInitiated—Outperform
Mar 19, 2026Wells FargoInitiated—Overweight
Mar 12, 2026WedbushMaintainedOutperformOutperform
Mar 10, 2026WedbushMaintainedOutperformOutperform
Mar 10, 2026Raymond JamesUpgradeOutperformStrong Buy
Mar 10, 2026BairdMaintainedOutperformOutperform
Mar 10, 2026Clear StreetMaintainedBuyBuy
Mar 9, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 9, 2026OppenheimerMaintainedOutperformOutperform
Mar 9, 2026Truist SecuritiesMaintainedBuyBuy
Mar 4, 2026GuggenheimMaintainedBuyBuy
Feb 11, 2026WedbushMaintainedOutperformOutperform
Feb 2, 2026JefferiesMaintainedBuyBuy
Jan 8, 2026Truist SecuritiesMaintainedBuyBuy
Dec 22, 2025WedbushReiteratedOutperformOutperform
Nov 10, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 6, 2025WedbushMaintainedOutperformOutperform
Oct 14, 2025Truist SecuritiesInitiated—Buy
Sep 17, 2025Clear StreetInitiated—Buy
Sep 12, 2025StifelMaintainedBuyBuy
Sep 12, 2025WedbushMaintainedOutperformOutperform